HRTX
Price:
$1.8
Market Cap:
$273.00M
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor...[Read more]
Industry
Biotechnology
IPO Date
1987-08-26
Stock Exchange
NASDAQ
Ticker
HRTX
According to Heron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 433.33M. This represents a change of -11.48% compared to the average of 489.55M of the last 4 quarters.
The mean historical Enterprise Value of Heron Therapeutics, Inc. over the last ten years is 975.49M. The current 433.33M Enterprise Value has changed 4.34% with respect to the historical average. Over the past ten years (40 quarters), HRTX's Enterprise Value was at its highest in in the June 2018 quarter at 2.57B. The Enterprise Value was at its lowest in in the September 2014 quarter at 156.84M.
Average
975.49M
Median
836.26M
Minimum
196.21M
Maximum
1.87B
Discovering the peaks and valleys of Heron Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 312.98%
Maximum Annual Enterprise Value = 1.87B
Minimum Annual Increase = -57.20%
Minimum Annual Enterprise Value = 196.21M
Year | Enterprise Value | Change |
---|---|---|
2023 | 385.78M | -6.88% |
2022 | 414.30M | -57.20% |
2021 | 967.99M | -47.41% |
2020 | 1.84B | -1.55% |
2019 | 1.87B | -0.09% |
2018 | 1.87B | 117.04% |
2017 | 862.23M | 60.77% |
2016 | 536.31M | -33.81% |
2015 | 810.30M | 312.98% |
2014 | 196.21M | 164.41% |
The current Enterprise Value of Heron Therapeutics, Inc. (HRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
589.36M
5-year avg
1.10B
10-year avg
975.49M
Heron Therapeutics, Inc.’s Enterprise Value is less than Mereo BioPharma Group plc (582.99M), less than Terns Pharmaceuticals, Inc. (458.36M), greater than PDS Biotechnology Corporation (74.53M), greater than Inozyme Pharma, Inc. (343.89M), greater than HOOKIPA Pharma Inc. (87.25M), greater than X4 Pharmaceuticals, Inc. (40.79M), greater than Acumen Pharmaceuticals, Inc. (93.64M), less than Day One Biopharmaceuticals, Inc. (1.01B), greater than Eledon Pharmaceuticals, Inc. (75.34M),
Company | Enterprise Value | Market cap |
---|---|---|
582.99M | $664.26M | |
458.36M | $549.60M | |
74.53M | $107.88M | |
343.89M | $312.42M | |
87.25M | $159.50M | |
40.79M | $109.78M | |
93.64M | $133.38M | |
1.01B | $1.25B | |
75.34M | $100.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Heron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Heron Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Heron Therapeutics, Inc. (HRTX)?
What is the 3-year average Enterprise Value for Heron Therapeutics, Inc. (HRTX)?
What is the 5-year average Enterprise Value for Heron Therapeutics, Inc. (HRTX)?
How does the current Enterprise Value for Heron Therapeutics, Inc. (HRTX) compare to its historical average?